Chemoinformaics analysis of tenacissoside A
Molecular Weight | 955.101 | nRot | 13 |
Heavy Atom Molecular Weight | 880.509 | nRig | 44 |
Exact Molecular Weight | 954.482 | nRing | 8 |
Solubility: LogS | -3.389 | nHRing | 4 |
Solubility: LogP | 1.642 | No. of Aliphatic Rings | 8 |
Acid Count | 0 | No. of Aromatic Rings | 0 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 4 |
Atoms Count | 141 | No. of Aliphatic Hetero Cycles | 4 |
No. of Heavy Atom | 67 | No. of Aromatic Carbocycles | 0 |
nHetero | 19 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 4 |
No. of Hydrogen atom | 74 | No. of Saturated Hetero Cycles | 4 |
No. of Carbon atom | 48 | No. of Saturated Rings | 8 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
No. of Oxygen atom | 19 | No. of Arom Bond | 0 |
nHA | 19 | APOL | 144.741 |
nHD | 5 | BPOL | 95.9373 |
QED | 0.076 |
Synth | 7.303 |
Natural Product Likeliness | 2.651 |
NR-PPAR-gamma | 0.151 |
Lipinski | Rejected |
Pfizer | Accepted |
GSK | Rejected |
Golden Triangle | Rejected |
Pgp-inh | 0.997 |
Pgp-sub | 0.996 |
HIA | 0.742 |
CACO-2 | -5.402 |
MDCK | 0.000214772 |
BBB | 0.03 |
PPB | 0.359801 |
VDSS | 0.426 |
FU | 0.179622 |
CYP1A2-inh | 0 |
CYP1A2-sub | 0.501 |
CYP2c19-inh | 0.002 |
CYP2c19-sub | 0.836 |
CYP2c9-inh | 0.001 |
CYP2c9-sub | 0.01 |
CYP2d6-inh | 0.002 |
CYP2d6-sub | 0.111 |
CYP3a4-inh | 0.154 |
CYP3a4-sub | 0.735 |
CL | 2.317 |
T12 | 0.017 |
hERG | 0.295 |
Ames | 0.134 |
ROA | 0.996 |
SkinSen | 0.01 |
Carcinogencity | 0.033 |
EI | 0.002 |
Respiratory | 0.669 |
NR-Aromatase | 0.883 |
Antiviral | Yes |
Prediction | 0.792404 |